From the Journals

Thoracic syndesmophytes common in ankylosing spondylitis


 

FROM JOURNAL OF RHEUMATOLOGY

Thoracic syndesmophytes are common in ankylosing spondylitis, even in the absence of lumbar syndesmophytes, according to a study published in the Journal of Rheumatology.

“Consequently, the involvement of the thoracic spine with syndesmophytes has not been widely studied,” they wrote. “If syndesmophytes differentially develop in the thoracic spine, exclusion of this large region may affect the validity of spinal fusion biomarker studies.”

In this study, 18 patients with ankylosing spondylitis who did not show complete lumbar fusion on radiographs underwent thoracolumbar CT and lumbar radiography (J Rheumatol. 2017 Oct 1. doi: 10.3899/jrheum.170340). The patients had ankylosing spondylitis for a mean duration of about 19 years, and 11 were treated with tumor necrosis factor inhibitors.

Researchers found syndesmophytes were common overall in intervertebral disc spaces, ranging from 56% to 89%. The rate of syndesmophytes peaked around the thoracolumbar junction, and bridging was both more evident and more extensive in the superior thoracic levels, compared with the lumbar levels.

In all the patients, thoracic syndesmophytes on the CT scan were at least as common as lumbar, and patients with extensive syndesmophytes at multiple lumbar locations typically also had the same in the thoracic region.

However, there were also patients with no, or very few, lumbar syndesmophytes on CT who still had thoracic syndesmophytes, some of which were extensive.

“Importantly, if syndesmophytes were observed on a lumbar radiograph, one could expect there to be syndesmophytes in the thoracic spine, but not the converse,” the authors wrote. “Several patients with normal lumbar radiographs had substantial thoracic syndesmophytes.”

The authors commented that because of its two-dimensional character, radiography has a relatively low sensitivity for detecting syndesmophytes, compared with CT. This could explain why patients with any syndesmophytes in the lumbar region on radiography also had them in the thoracic CT scans.

“By the time syndesmophytes are detectable on lumbar radiographs, structural damage may already have occurred in large portions of the thoracolumbar spine.”

They acknowledged that their method was a research tool and not intended for clinical practice, but also pointed out that CT technology had improved to allow more extensive spine coverage, at an equal effective dose, without compromising scan quality.

The study was supported by the National Institutes of Health. No conflicts of interest disclosures were available.

Recommended Reading

First interchangeability study for an adalimumab biosimilar has begun
MDedge Rheumatology
Radiographic progression in axial spondyloarthritis moves slowly in first 5 years
MDedge Rheumatology
Axial SpA features don’t guarantee its diagnosis in chronic back pain
MDedge Rheumatology
FDA approves second adalimumab biosimilar for multiple conditions
MDedge Rheumatology
New recommendations tout biosimilars for rheumatologic diseases
MDedge Rheumatology
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nod
MDedge Rheumatology
Ultrasound’s value for arthralgia may be to rule out IA
MDedge Rheumatology
Early ankylosing spondylitis treatment stops transition from inflammatory to bone-forming fatty lesions
MDedge Rheumatology
Immunogenicity concerns for biosimilars so far don’t go beyond originator biologics
MDedge Rheumatology
Launch of adalimumab biosimilar Amjevita postponed
MDedge Rheumatology

Related Articles